Ancora Capital Challenges Netflix Deal for Warner Bros. Discovery
Activist investor backs rival Paramount offer, escalating high-stakes Hollywood takeover battle A new twist has emerged in the takeover battle ...
Tag: Stock Market
Robinhood Shares Slide After Revenue Miss Dampens Record Year
Strong annual growth overshadowed by softer crypto and options trading in the fourth quarter Robinhood Markets shares fell sharply in ...
Ford Posts Heavy Losses as EV Charges and Warranty Costs Weigh on Results
Automaker misses earnings expectations but signals confidence in a multi-year turnaround Ford Motor Company (F) reported weaker-than-expected fourth-quarter results Tuesday ...
Coca-Cola Shares Slip as Management Strikes a Cautious Tone for 2026
Prudent outlook and international pressures overshadow steady demand for zero-sugar and hydration brands The Coca-Cola Company shares fell as much ...
Why KULR Could Be a Quiet Enabler of Space-Based Solar Power (SBSP) Over the Long Term
One area of the space economy that doesn’t get much attention yet, but keeps quietly attracting government and private capital, ...
FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims
Regulatory scrutiny adds pressure as competition intensifies in the booming GLP-1 market Food and Drug Administration has issued a warning ...
Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism
Massive cloud capex plans ease fears that AI will sideline enterprise software Oracle Corp. (ORCL) shares surged Monday, extending a ...
Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
Regulatory crackdown and Novo Nordisk lawsuit rattle investors and reshape weight-loss drug landscape Shares of Hims & Hers Health (HIMS) ...
Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets
Automaker posts 2025 net loss after acknowledging missteps in the pace of the energy transition Stellantis shocked markets after announcing ...
Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery
If demand stabilizes, cost savings stick, and digital/aligners re-accelerate, XRAY could re-rate sharply Dentsply Sirona (XRAY) has been treated like ...
